China To Launch Anti-Dumping Measures Against Japan, Indian Pyridine
This article was originally published in PharmAsia News
China’s Ministry of Commerce has launched anti-dumping measures against Japan and Indian-made pyridine, including charging security deposits in accordance with its recent ruling from relevant importers.
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.